Techseriesinsight
  • Home
  • News
    • Advertising & Promotion
      • Content Marketing
      • Marketing Automation
      • Press Release
      • Sales & Marketing
      • Social Media
    • Analytics
      • Cloud
      • Data Center
      • Data Management Platform
      • Storage
    • Artificial Intelligence
      • RoboticsExplore the latest in robotics tech news. Stay updated on innovations, trends, and developments in this exciting field.
    • Biotechnology
    • Business Broadcast
    • Customer Experience
    • E-Commerce
    • Healthcare
    • Joint Ventures
    • Networking
      • Blockchain TechnologyBlockchain Technology
      • Internet of Things (IoT)Internet of Things (IoT)
    • Security
  • Insights
  • Resource Hub
    • AI / ML
    • Cloud Technology
    • Customer Engagement
    • Information Technology
    • Security
    • Tech & Work
Techseriesinsight
Techseriesinsight
  • Home
  • News
    • Advertising & Promotion
      • Content Marketing
      • Marketing Automation
      • Press Release
      • Sales & Marketing
      • Social Media
    • Analytics
      • Cloud
      • Data Center
      • Data Management Platform
      • Storage
    • Artificial Intelligence
      • RoboticsExplore the latest in robotics tech news. Stay updated on innovations, trends, and developments in this exciting field.
    • Biotechnology
    • Business Broadcast
    • Customer Experience
    • E-Commerce
    • Healthcare
    • Joint Ventures
    • Networking
      • Blockchain TechnologyBlockchain Technology
      • Internet of Things (IoT)Internet of Things (IoT)
    • Security
  • Insights
  • Resource Hub
    • AI / ML
    • Cloud Technology
    • Customer Engagement
    • Information Technology
    • Security
    • Tech & Work

Biotechnology

Techseriesinsight > Blog > News > Biotechnology
  • November 15, 2024
  • Business Wire
  • Biotechnology

Anaergia Awarded Contract to Operate and Maintain Rialto Bioenergy Solutions Facility in California

Anaergia Inc. (“Anaergia”, the “Company”, “we”, “us”, or “our”) (TSX: ANRG) announced today that its subsidiary, Anaergia Services LLC (“Anaergia Services”), has entered into a long-term Operations and Maintenance...
Continue Reading
  • November 15, 2024
  • PRNewswire
  • Biotechnology

Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas–Inherited Gastrointestinal Cancers

Immunovia (NASDAQ Stockholm: IMMNOV), the pancreatic cancer diagnostics company, will present results from the recently completed model-development study of the company’s next-generation test at the 2024 annual meeting of...
Continue Reading
  • November 13, 2024
  • Business Wire
  • Biotechnology

GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today...
Continue Reading
  • November 13, 2024
  • Business Wire
  • Biotechnology

VIVOLTA Partners with Neurochase to Manufacture Electrospun Micro-Catheters Delivering Advanced CNS Therapies to the Brain

VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership with Neurochase, the CNS (central nervous system) delivery platform specialist, to manufacture electrospun micro-catheters to deliver advanced therapies...
Continue Reading
  • November 13, 2024
  • Business Wire
  • Biotechnology

CARMAT’s Aeson® Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe

CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the...
Continue Reading
  • November 12, 2024
  • Business Wire
  • Biotechnology

Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial

Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an investigational medicine being developed by Abbisko Therapeutics Co., Ltd., met its...
Continue Reading
  • November 8, 2024
  • PRNewswire
  • Biotechnology

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, today announced the...
Continue Reading
  • November 8, 2024
  • PRNewswire
  • Biotechnology

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

 Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced positive pre-clinical data on its anti-GPC3 in vivo chimeric antigen receptor...
Continue Reading
  • November 7, 2024
  • Business Wire
  • Biotechnology

Murata’s Revolutionary Stretchable Printed Circuit Elevates Wearable Medical Devices

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) reveals an innovative new Stretchable Printed Circuit (SPC) technology marking a significant development in printed circuit technology. Murata’s SPC represents the...
Continue Reading
  • November 7, 2024
  • Business Wire
  • Biotechnology

MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting Demonstrating Prolonged Long-Term Survival in Patients Receiving MaaT013 in aGvHD

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through...
Continue Reading

Posts navigation

Previous 1 … 42 43 44 … 50 Next

Search

Newsletter

Subscribe Our Free Newsletter

Loading

Get in Touch

  • 750 Followers
  • 950 Likes
  • 1250 Fans
  • 1050 Followers

Recent Posts

Kaiser Permanente invests $15M for behavioral health care
Kaiser Permanente invests $15M for behavioral… October 28, 2026
Wealthbox Launches Vault, Advanced File Storage for Advisory
Wealthbox Launches Vault, Advanced File Storage… October 28, 2026
Formation Bio
Formation Bio Announces $600 Million Debut… October 28, 2026
NiCE Publishes 2025 Environmental, Social and Governance
Netrio Recognized on the CRN® AI… October 28, 2026
Stellar
Movantis Integrates with the Stellar Network… October 28, 2026

Hot Categories

Techseriesinsight

Techseriesinsight is a global digital platform that publishes content related to technology and business insights from industry experts. Get the latest news, discussions & strategic expertise with thoughts and assessments on business challenges.

Follow us

Quick links

  • Contact Us
  • Privacy Policy
  • Unsubscribe

Subscribe Our Free Newsletter

Loading

Techseriesinsight, 2026 © All Rights Reserved